Las Vegas, Nevada, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hestia Insight Inc. today announced that its wholly owned subsidiary, Hestia Investments Inc., (SYMBOL:HSTA), has begun providing strategic consulting and capital market advisory services for selective micro, small and medium sized companies in the healthcare, biotech and fintech sectors.
“We will also provide seed capital and mezzanine funding for qualified emerging companies in these three sectors,” said Edward C. Lee, Chairman and CEO.
Mr. Lee is a veteran investment banker and entrepreneur with more than 30-years’ experience managing public and private companies both in U.S. and Greater China. For more information please visit www.hestiainsight.com
("Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.)
Pink Current Company:
Edward Lee CEO profile on LinkedIn
OTC MArkets page: https://www.otcmarkets.com/stock/HSTA/overview
Held at DTC